BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Docket Clock//docket-clock.pages.dev//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Leveraging Prior Knowledge in the Development of Human Gene 
X-PUBLISHED-TTL:PT12H
REFRESH-INTERVAL;VALUE=DURATION:PT12H
BEGIN:VEVENT
UID:2026-11054-close@docket-clock.pages.dev
DTSTAMP:20261017T145145Z
DTSTART;VALUE=DATE:20260901
DTEND;VALUE=DATE:20260902
SUMMARY:FDA comments close: Leveraging Prior Knowledge in the Development 
 of Human Gene Therapy Products Incorporating Genome Editing\; Draft Guida
 nce for Industry\; Availability
DESCRIPTION:Notice. Federal Register 2026-11054. Docket FDA-2026-D-1257. D
 etails: https://docket-clock.pages.dev/doc/2026-11054/ Official: https://
 www.federalregister.gov/documents/2026/06/03/2026-11054/leveraging-prior-
 knowledge-in-the-development-of-human-gene-therapy-products-incorporating
 -genome
URL:https://www.federalregister.gov/documents/2026/06/03/2026-11054/levera
 ging-prior-knowledge-in-the-development-of-human-gene-therapy-products-in
 corporating-genome
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR